Literature DB >> 1929267

Cocaine hydrochloride and benzoylecgonine have no in vitro inhibitory effect against Neisseria gonorrhoeae.

J M Zenilman1, C A Reichart, T M Neumann, E W Hook.   

Abstract

We evaluated 72 clinical Neisseria gonorrhoeae isolates for in vitro susceptibility to cocaine hydrochloride and its metabolite benzoylecgonine and to penicillin, tetracycline, erythromycin, ceftriaxone, and ofloxacin. Although there was a wide range of susceptibilities to the antimicrobial agents, cocaine and its major metabolite, benzoylecgonine, had no demonstrable antigonococcal activity. Cocaine use is frequently associated with outbreaks of sexually transmitted disease. We hypothesized that the dramatically decreasing incidence of gonorrhea over the past 15 years may be in part due to pharmacological effects of cocaine. However, since cocaine and its metabolite have no in vitro antigonococcal activity, this hypothesis is unlikely.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929267      PMCID: PMC284316          DOI: 10.1128/AAC.35.6.1228

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Prevalence of recent cocaine use among motor vehicle fatalities in New York City.

Authors:  P M Marzuk; K Tardiff; A C Leon; M Stajic; E B Morgan; J J Mann
Journal:  JAMA       Date:  1990-01-12       Impact factor: 56.272

2.  Inhibition of microorganisms by topical anesthetics.

Authors:  J Kleinfeld; P P Ellis
Journal:  Appl Microbiol       Date:  1967-11

3.  Cocaine use and HIV infection in intravenous drug users in San Francisco.

Authors:  R E Chaisson; P Bacchetti; D Osmond; B Brodie; M A Sande; A R Moss
Journal:  JAMA       Date:  1989-01-27       Impact factor: 56.272

4.  National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project.

Authors:  S K Schwarcz; J M Zenilman; D Schnell; J S Knapp; E W Hook; S Thompson; F N Judson; K K Holmes
Journal:  JAMA       Date:  1990-09-19       Impact factor: 56.272

Review 5.  Drug of abuse profile: cocaine.

Authors:  P I Jatlow
Journal:  Clin Chem       Date:  1987-10       Impact factor: 8.327

6.  Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline.

Authors:  R N Jones; T L Gavan; C Thornsberry; P C Fuchs; E H Gerlach; J S Knapp; P Murray; J A Washington
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

7.  Cocaine: plasma concentrations after intranasal application in man.

Authors:  C Van Dyke; P G Barash; P Jatlow; R Byck
Journal:  Science       Date:  1976-02-27       Impact factor: 47.728

8.  Risk of sexually transmitted disease among black adolescent crack users in Oakland and San Francisco, Calif.

Authors:  R E Fullilove; M T Fullilove; B P Bowser; S A Gross
Journal:  JAMA       Date:  1990-02-09       Impact factor: 56.272

9.  Antibacterial properties of lidocaine.

Authors:  N Wimberley; S Willey; N Sullivan; J G Bartlett
Journal:  Chest       Date:  1979-07       Impact factor: 9.410

10.  Plasma cocaine concentrations during cocaine paste smoking.

Authors:  D Paly; P Jatlow; C Van Dyke; F R Jeri; R Byck
Journal:  Life Sci       Date:  1982-03-01       Impact factor: 5.037

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.